Published in Gastroenterology on February 20, 2010
Diet-induced adaptation of vagal afferent function. J Physiol (2011) 1.08
Ghrelin-induced adiposity is independent of orexigenic effects. FASEB J (2011) 0.97
Influence of a long-term high-fat diet on ghrelin secretion and ghrelin-induced food intake in rats. Regul Pept (2011) 0.84
Neuroactive peptides as putative mediators of antiepileptic ketogenic diets. Front Neurol (2014) 0.84
Obesity Impairs the Action of the Neuroendocrine Ghrelin System. Trends Endocrinol Metab (2015) 0.81
Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. ILAR J (2012) 0.81
Differential gene regulation of GHSR signaling pathway in the arcuate nucleus and NPY neurons by fasting, diet-induced obesity, and 17β-estradiol. Mol Cell Endocrinol (2015) 0.80
Diet-induced obesity causes peripheral and central ghrelin resistance by promoting inflammation. J Endocrinol (2015) 0.80
Effect of ghrelin receptor antagonist on meal patterns in cholecystokinin type 1 receptor null mice. Physiol Behav (2011) 0.78
The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol (2017) 0.77
Bowels control brain: gut hormones and obesity. Biochem Med (Zagreb) (2012) 0.77
Neonatal events, such as androgenization and postnatal overfeeding, modify the response to ghrelin. Sci Rep (2014) 0.76
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass. Ann Surg (2007) 3.02
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Early generalized overgrowth in boys with autism. Arch Gen Psychiatry (2011) 1.40
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology (2004) 1.31
Valerian for sleep: a systematic review and meta-analysis. Am J Med (2006) 1.31
TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to diesel exhaust particles. Environ Health Perspect (2011) 1.29
Gastrointestinal satiety signals. Annu Rev Physiol (2008) 1.27
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab (2006) 1.26
The role of gut hormones and the hypothalamus in appetite regulation. Endocr J (2010) 1.24
Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol (2010) 1.23
The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci (2003) 1.22
Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology (2012) 1.20
Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg (2010) 1.20
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr (2007) 1.19
Screening for autism spectrum disorders in 12-month-old high-risk siblings by parental report. J Autism Dev Disord (2015) 1.19
MicroRNA regulation of molecular networks mapped by global microRNA, mRNA, and protein expression in activated T lymphocytes. J Immunol (2011) 1.18
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol (2005) 1.18
Patterns of lateral neck metastasis in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2004) 1.16
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver (2012) 1.16
Localization of Smc5/6 to centromeres and telomeres requires heterochromatin and SUMO, respectively. EMBO J (2008) 1.16
Gut hormones and the control of appetite. Trends Endocrinol Metab (2004) 1.15
Lack of association between impaired glucose tolerance and appetite regulating hormones in patients with obstructive sleep apnea. J Clin Sleep Med (2011) 1.14
Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab (2005) 1.14
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res (2005) 1.14
Molecular mechanisms of chronic kidney transplant rejection via large-scale proteogenomic analysis of tissue biopsies. J Am Soc Nephrol (2010) 1.13
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes (2012) 1.13
Ghrelin for the gastroenterologist: history and potential. Gastroenterology (2003) 1.12
Triiodothyronine stimulates food intake via the hypothalamic ventromedial nucleus independent of changes in energy expenditure. Endocrinology (2004) 1.12
Eating slowly increases the postprandial response of the anorexigenic gut hormones, peptide YY and glucagon-like peptide-1. J Clin Endocrinol Metab (2009) 1.11
The role of oxyntomodulin and peptide tyrosine-tyrosine (PYY) in appetite control. Nat Clin Pract Endocrinol Metab (2006) 1.10
Failed back surgery syndrome: diagnostic evaluation. J Am Acad Orthop Surg (2006) 1.08
The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab (2011) 1.08
Fat digestion is required for suppression of ghrelin and stimulation of peptide YY and pancreatic polypeptide secretion by intraduodenal lipid. Am J Physiol Endocrinol Metab (2005) 1.08
Differential hypothalamic neuronal activation following peripheral injection of GLP-1 and oxyntomodulin in mice detected by manganese-enhanced magnetic resonance imaging. Biochem Biophys Res Commun (2006) 1.07
Distinct distribution of specific members of protein 4.1 gene family in the mouse nephron. Kidney Int (2003) 1.07
Predicting developmental status from 12 to 24 months in infants at risk for Autism Spectrum Disorder: a preliminary report. J Autism Dev Disord (2012) 1.07
Peripheral and central administration of xenin and neurotensin suppress food intake in rodents. Obesity (Silver Spring) (2009) 1.06
Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study. Crit Care (2006) 1.05
Obesity and appetite control. Exp Diabetes Res (2012) 1.05
Identification of hypothalamic nuclei involved in the orexigenic effect of melanin-concentrating hormone. Endocrinology (2003) 1.04
Deconvoluting post-transplant immunity: cell subset-specific mapping reveals pathways for activation and expansion of memory T, monocytes and B cells. PLoS One (2010) 1.03
Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood. PLoS One (2009) 1.03
Sexual dimorphism of kisspeptin and neurokinin B immunoreactive neurons in the infundibular nucleus of aged men and women. Front Endocrinol (Lausanne) (2011) 1.02
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. J Clin Endocrinol Metab (2005) 1.02
Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol (2009) 1.01
A randomised four-intervention crossover study investigating the effect of carbohydrates on daytime profiles of insulin, glucose, non-esterified fatty acids and triacylglycerols in middle-aged men. Br J Nutr (2003) 1.01
Peptides and their potential role in the treatment of diabetes and obesity. Rev Diabet Stud (2011) 1.01
Can gut hormones control appetite and prevent obesity? Diabetes Care (2008) 1.00
Prenatal polycyclic aromatic hydrocarbon exposure leads to behavioral deficits and downregulation of receptor tyrosine kinase, MET. Toxicol Sci (2010) 1.00
Minireview: Gut peptides regulating satiety. Endocrinology (2004) 0.99
Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg (2007) 0.98
Mice with hyperghrelinemia are hyperphagic and glucose intolerant and have reduced leptin sensitivity. Diabetes (2009) 0.98